Mount Sinai Institute for Systems Biomedicine

Medicine & Life Sciences

1. Adenylyl Cyclases 21%
2. Allografts 36%
3. Antibodies 18%
4. Antidepressive Agents 52%
5. Anxiety 20%
6. Bariatric Surgery 18%
7. Binding Sites 18%
8. Biomarkers 18%
9. Bone and Bones 21%
10. Brain 58%
11. Brain-Derived Neurotrophic Factor 19%
12. Cannabinoid Receptors 29%
13. Cardiac Myocytes 30%
14. Chronic Disease 37%
15. Cocaine 39%
16. Collagen 34%
17. Coronavirus 28%
18. Critical Illness 33%
19. Delivery of Health Care 18%
20. delta Opioid Receptor 21%
21. Depression 80%
22. Dimerization 19%
23. Dopaminergic Neurons 21%
24. Drug Development 21%
25. Drug Discovery 20%
26. Elastic Tissue 18%
27. Endocrinologists 53%
28. Endocrinology 37%
29. Epigenomics 18%
30. Fibrillin-1 65%
31. Fibrillin-2 30%
32. Fibrillins 43%
33. G-Protein-Coupled Receptors 93%
34. Gene Expression 26%
35. Genes 61%
36. GTP-Binding Proteins 40%
37. Guidelines 19%
38. Habenula 24%
39. Heart 27%
40. Heart Failure 42%
41. Heart Transplantation 37%
42. Heart-Assist Devices 60%
43. Induced Pluripotent Stem Cells 24%
44. Integrins 18%
45. Ketamine 75%
46. Kidney 41%
47. Kidney Transplantation 25%
48. Life Style 32%
49. Ligands 56%
50. Machine Learning 18%
51. Major Depressive Disorder 76%
52. Marfan Syndrome 69%
53. Medicine 26%
54. Messenger RNA 18%
55. Microfibrils 38%
56. Molecular Dynamics Simulation 36%
57. Mood Disorders 18%
58. Morphine 41%
59. Mortality 20%
60. Muscle Cells 21%
61. Mutation 39%
62. Neuronal Plasticity 23%
63. Neurons 46%
64. Neuropeptides 20%
65. Nicotine 18%
66. Nucleus Accumbens 66%
67. Obesity 36%
68. Opioid Analgesics 39%
69. Opioid Receptors 100%
70. Optogenetics 21%
71. Pandemics 19%
72. Peptides 43%
73. Pharmaceutical Preparations 47%
74. Pharmacology 45%
75. Phenotype 28%
76. Phosphotransferases 30%
77. Podocytes 38%
78. Population 23%
79. Post-Traumatic Stress Disorders 27%
80. Practice Guidelines 33%
81. Prefrontal Cortex 20%
82. Proteins 44%
83. Proteomics 18%
84. Randomized Controlled Trials 20%
85. Reward 60%
86. Signal Transduction 26%
87. Substance-Related Disorders 23%
88. Systems Biology 19%
89. Theoretical Models 18%
90. Therapeutics 51%
91. Thyroid Neoplasms 19%
92. Tissue Donors 19%
93. Transforming Growth Factors 20%
94. Transplant Recipients 37%
95. Transplantation 22%
96. Transplants 49%
97. Treatment-Resistant Depressive Disorder 49%
98. Type 2 Diabetes Mellitus 35%
99. Ventral Tegmental Area 45%
100. Wounds and Injuries 23%